Dachaigh › Luchd-obrach › Karuna Therapeutics, Inc.
Karuna Therapeutics, Inc.: Tuarastalan H-1B agus taic bhìosa
Chuir Karuna Therapeutics, Inc. 7 iarrtasan cumha-obrach a-steach airson bhìosaichean H-1B agus bhìosaichean co-cheangailte ann am bliadhnaichean ionmhais 2023–2026; le teisteanas: 6. Tuarastal meadhanach a chaidh a thabhann: $177,500.
A bheil Karuna Therapeutics, Inc. a’ toirt taic do bhìosaichean H-1B?
Chuir Karuna Therapeutics, Inc. 7 iarrtasan cumha-obrach a-steach ann am bliadhnaichean ionmhais 2023–2026, an tè as ùire air a chur a-steach air 13 Iuch 2023. Is e LCA a’ chiad cheum ann an iarrtas H-1B, mar sin tha an neach-fastaidh air taic a thoirt do luchd-obrach H-1B no air ullachadh airson sin a dhèanamh; cha gharantaich e taic airson dreuchd shònraichte sam bith. Thoir sùil air liostaichean obrach an neach-fastaidh fhèin.
Tuarastalan a rèir tiotal obrach
| Tiotal dreuchd | LCAs | Tuarastal meadhanach |
|---|---|---|
| Real World Evidence Data Scientist | 2 | $185,000 |
| Senior Manager, Analytical Development | 1 | $150,000 |
| Senior Manager, Quality Assurance CMC | 1 | $148,824 |
| Sr. Director Commercial & Analytics Operations | 1 | $250,000 |
| Director, Pharmacovigilance Scientist | 1 | $225,000 |
| Senior Manager, Drug Product Commercial Manufacturing | 1 | $170,000 |
Iarrtasan a rèir bliadhna ionmhais
| Bliadhna mhaoine | LCAs | Tuarastal meadhanach |
|---|---|---|
| FY2023 | 7 | $177,500 |
Ìrean tuarastail làithreach
Suidhichidh Roinn an Obrach ceithir ìrean tuarastail làithreach airson gach dreuchd agus sgìre, bho Ìre I (inntrigeadh) gu Ìre IV (gu tur comasach). Taghaidh an neach-fastaidh an ìre a fhreagras ri riatanasan na h-obrach.
Far a bheil na h-obraichean
Dreuchdan
- Data Scientists2
- Biochemists and Biophysicists1
- Industrial Production Managers1
- Computer and Information Systems Managers1
- Medical Scientists, Except Epidemiologists1
- Chemists1
Iarrtasan as ùire
| Tiotal dreuchd | Tuarastal bunasach | Àite | Air a chur a-steach | Ceann-latha tòiseachaidh | Inbhe |
|---|---|---|---|---|---|
| Senior Manager, Drug Product Commercial Manufacturing | $170,000 Ìre III | Boston, MA | 13 Iuch 2023 | 24 Iuch 2023 | Dearbhaichte |
| Director, Pharmacovigilance Scientist | $225,000–$250,000 Ìre III | Boston, MA | 16 Cèit 2023 | 22 Cèit 2023 | Dearbhaichte |
| Senior Manager, Analytical Development | $150,000 Ìre III | Floor 26, MA | 22 Gearr 2023 | 6 Màrt 2023 | Dearbhaichte |
| Senior Manager, Quality Assurance CMC | $148,824 Ìre III | Boston, MA | 6 Gearr 2023 | 27 Iuch 2023 | Dearbhaichte |
| Sr. Director Commercial & Analytics Operations | $250,000 Ìre IV | Secaucus, NJ | 31 Faoi 2023 | 13 Gearr 2023 | Dearbhaichte |
| Real World Evidence Data Scientist | $185,000 Ìre IV | Fort Worth, TX | 9 Samh 2022 | 14 Samh 2022 | Dearbhaichte |
| Real World Evidence Data Scientist | $185,000 Ìre IV | Fort Worth, TX | 9 Samh 2022 | 14 Samh 2022 | Air a tharraing air ais |
Is e na tuarastalan an ìre as ìsle den tuarastal a chaidh a thabhann air gach iarrtas, air an tionndadh gu suim bhliadhnail; cleachdaidh na staitistigean iarrtasan làn-aimsire le teisteanas a-mhàin. Chan eil LCA na aontachadh bhìosa agus faodaidh aon LCA còmhdach a dhèanamh air iomadh dreuchd. Stòr: Roinn an Obrach na SA, Dàta Foillseachaidh OFLC LCA, bliadhnaichean ionmhais 2023–2026 (co-dhùnadh as ùire 30 Ògmh 2026).